Financial Performance - Q3 2025 revenue was CNY 198,739,228.29, a decrease of 14.14% year-over-year[5] - Net profit attributable to shareholders was CNY -26,947,248.76, an increase of 6.46% compared to the same period last year[5] - Year-to-date net profit attributable to shareholders reached CNY -111,893,091.84, a decrease of 42.83% year-over-year[5] - Total profit (loss) decreased by 40.43% to CNY -109,976,180.17, mainly due to increased R&D investments[10] - Net profit (loss) decreased by 42.83% to CNY -111,893,079.44, attributed to increased R&D expenditures[10] - The net loss for the current period was ¥111,893,079.44, compared to a net loss of ¥78,337,836.91 in the previous period, indicating a deterioration in financial performance[20] Earnings Per Share - Basic and diluted earnings per share for Q3 2025 were CNY -0.0792, reflecting a 6.71% increase year-over-year[5] - Basic and diluted earnings per share decreased by 42.49% to CNY 0.3290, reflecting the impact of increased R&D investments[11] - Basic and diluted earnings per share for the current period were both -¥0.3290, compared to -¥0.2309 in the previous period, indicating a worsening in earnings per share[20] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 2,268,241,657.15, down 8.21% from the end of the previous year[5] - Total current assets amount to 1,258,744,807.73 CNY, an increase from 1,211,633,768.81 CNY at the beginning of the period[17] - Total non-current assets decreased to 1,009,496,849.42 CNY from 1,259,392,664.42 CNY[17] - The total liabilities decreased to ¥529,533,710.03 from ¥635,648,000.55, a reduction of about 16.67%[18] - The total equity attributable to shareholders decreased to ¥1,738,685,829.72 from ¥1,835,356,327.68, a decline of approximately 5.9%[18] Cash Flow - Cash flow from operating activities year-to-date was CNY -250,088,784.85, a decrease of 47.46%[5] - Cash flow from operating activities decreased by 47.46% to CNY -250,088,784.85, primarily due to increased cash payments for goods and services[11] - Cash flow from investing activities decreased by 79.62% to CNY 227,469,178.55, mainly due to reduced cash payments for investments[11] - The company reported a significant decrease in cash received from investment recoveries, totaling $251,315,400.00, compared to $1,317,482,870.70 previously[23] - The company’s cash flow from operating activities remains negative, highlighting ongoing challenges in cash generation[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 101,316[14] - The largest shareholder, Shen Sa, holds 8.12% of shares, totaling 27,623,918 shares, with 9,360,000 shares pledged[14] - The second-largest shareholder, Huabao Zhongzheng Financial Technology Theme ETF, holds 1.64% of shares, totaling 5,575,908 shares[14] Research and Development - Unallocated profits decreased by 31.78% to CNY -463,973,121.71 primarily due to increased R&D expenditures[10] - Research and development expenses rose to ¥144,719,751.67, up from ¥125,611,630.78, reflecting an increase of approximately 15.2%[19] - Interest expenses increased by 128.35% to CNY 1,577,683.84 due to higher bank loan interest payments compared to the previous period[10] - Total comprehensive income attributable to shareholders decreased by 42.84% to CNY -111,894,299.97, primarily due to increased R&D expenditures[10]
中科金财(002657) - 2025 Q3 - 季度财报